Last reviewed · How we verify

Ferrous sulfate + folic acid

Ifakara Health Institute · FDA-approved active Small molecule

Ferrous sulfate provides bioavailable iron to treat iron deficiency anemia, while folic acid (vitamin B9) supports red blood cell formation and DNA synthesis.

Ferrous sulfate provides bioavailable iron to treat iron deficiency anemia, while folic acid (vitamin B9) supports red blood cell formation and DNA synthesis. Used for Iron deficiency anemia, Folic acid deficiency anemia, Anemia prevention in pregnancy.

At a glance

Generic nameFerrous sulfate + folic acid
Also known asFefo, Iron Tablets
SponsorIfakara Health Institute
Drug classNutritional supplement / hematologic agent
ModalitySmall molecule
Therapeutic areaHematology / Nutritional deficiency
PhaseFDA-approved

Mechanism of action

Ferrous sulfate is an iron supplement that replenishes depleted iron stores, which are essential for hemoglobin synthesis and oxygen transport in red blood cells. Folic acid is a B vitamin cofactor required for nucleotide synthesis and cell division, particularly important in erythropoiesis. Together, they address two common nutritional deficiencies that contribute to anemia, particularly in populations at risk such as pregnant women and those in resource-limited settings.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: